Comments
Commented by Nico Popp on October 5th, 2023 | 08:35 CEST
Future investments that will soon ignite: Volkswagen, JinkoSolar, Defense Metals
Do you wish you had a crystal ball? What a question! Those who know the future could make great profit from it. But even without magical powers, one can succeed in consistently aligning your portfolio with the future. We explain how this works and what investors need to watch out for. In addition, we present three companies with great future potential and highlight when investments could be worthwhile and when investors would be better to wait and see.
Read
Commented by Fabian Lorenz on October 5th, 2023 | 07:10 CEST
Buy biotech stocks now? BioNTech, Morphosys and Cardiol Therapeutics in check
In times of high interest rates, the wheat is separated from the chaff, even in the biotech sector. After all, young research-based companies, in particular, have a high demand for capital. But at the moment, all companies are being lumped together. This opens up clear buying opportunities because some have full coffers. BioNTech belongs to this group. Thanks to the COVID-19 vaccine, research is fully financed. The same goes for Cardiol Therapeutics. The share of the Canadians is one of the summer's high flyers, and the recent price setback offers an entry opportunity. The analysts' price target is over 300% above the current level. And what do analysts say about the German biotech veteran Morphosys? Goldman Sachs has tripled its price target.
Read
Commented by Fabian Lorenz on October 4th, 2023 | 08:15 CEST
Battery vs. hydrogen! Buy Nel ASA now? Or is FREYR Battery or Altech Advanced Materials better?
Should investors bet on battery stocks over hydrogen stocks? At least when looking at investor darlings like Nel and Plug Power, the answer to this question seems to be "yes" at the moment. The Nel share, in particular, has been hit hard. In local currency, it is trading at its lowest level since the beginning of 2020. Is there hope for a rebound? Or are investors better off betting on battery newcomers like FREYR Battery or Altech Advanced Materials? In terms of share price, Germany's Altech has been the best performer this year, and at the recent Capital Markets Day, management expressed confidence that it would soon take the battery market by storm. So, what is the current status of hopes for hydrogen and batteries?
Read
Commented by Stefan Feulner on October 4th, 2023 | 08:05 CEST
Coinbase, Smartbroker Holding, MicroStrategy - Strong upward wave expected
No sooner does the world's largest cryptocurrency surpass the USD 28,000 mark than the bulls increasingly enter the market and announce gigantic price targets. In view of the upcoming halving in April next year, which will inevitably lead to a supply shortage, market experts assume a six-digit price level for bitcoin. Profiteers of the expected bull run include not only Bitcoin holders but also cryptocurrency exchanges and online brokers that facilitate trading on their platforms.
Read
Commented by André Will-Laudien on October 4th, 2023 | 07:50 CEST
Mega battery deal at First Phosphate, BASF, VW and BYD with buy signals
The last IAA in Munich was a memorable showdown for the local automotive industry. More than 750 exhibitors from 109 countries showcased their e-mobility innovations. In addition to autonomous driving with AI support and various new technical features, however, one topic in particular preoccupied trade visitors: how can manufacturers get more power, longevity and safety into powertrain batteries? Li-ion technology has now been in use for over 20 years. But where is the future state of the art? BASF and First Phosphate have new developments to offer in this regard. Manufacturers like BYD and Volkswagen have the global market shares to make these innovations fly. Where should investing be done now?
Read
Commented by Armin Schulz on October 2nd, 2023 | 08:25 CEST
First Phosphate, Volkswagen, Varta - Battle for battery raw materials picks up speed
The global demand for electric vehicles is steadily increasing, driving the need for battery raw materials. However, the battle for these coveted raw materials has political consequences, particularly concerning the strained relations between the US and China. The US has recognized that it is heavily dependent on China for access to key battery raw materials, which has led to tensions between the two countries. The US is working to reduce these dependencies. This is reason enough to examine three companies that rely on battery raw materials.
Read
Commented by Stefan Feulner on October 2nd, 2023 | 08:10 CEST
Rheinmetall AG, Almonty Industries, Commerzbank - A run-up to the end of the year
After a strong first half, the stock markets corrected in the third quarter, driven by continuing risks such as high inflation, rising interest rates and the weakening economy with existing recession scenarios. The commodity markets were also unable to decouple themselves from this. Nevertheless, there are opportunities for a year-end rally in the final quarter.
Read
Commented by Nico Popp on October 2nd, 2023 | 07:55 CEST
Tremors in the Industry - What goes, What stays: ThyssenKrupp, First Hydrogen, BYD
ThyssenKrupp no longer wants to be (almost) just a steel conglomerate. Donald Trump sees the transition to sustainable transportation as an attack on the industry, and in parallel, Germany is pondering how to change course. We shed light on the tremors in the industry and explain which technologies are yesterday's news and where new long-term potential is emerging. This much can be revealed in advance: Surprises lurk off the well-trodden tracks!
Read
Commented by André Will-Laudien on October 2nd, 2023 | 07:45 CEST
CO2 Certificates - The Solution for Climate Change? Nel ASA, Klimat X, Ballard Power and Plug Power in the analysis check!
The transition to a sustainable climate cannot be solely funded by the public. Success depends on private initiatives. It is, therefore, all the more important that inventiveness and entrepreneurial energy in this critical economic sector are also rewarded and promoted. In May 2022, the European Union launched REPowerEU, a billion-dollar program on how to shape the energy future. At the time, hydrogen accounted for less than 2% of energy consumption in Europe and was mainly used to manufacture chemical products such as plastics and fertilizers. The European Commission has proposed producing about 10 million tons of renewable hydrogen by 2030 and importing another 10 million tons to reduce climate-damaging gases. Climate innovations are evaluated differently on the stock market, and we will focus on some key players.
Read
Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST
Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization
According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.
Read